Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect and Safety of Postbiotic MBS and Metformin Combination on Gut Microbiota and Symptom in Patients With Diabetes

NCT04639492 is registered in ClinicalTrials.gov with Microbio Co Ltd as lead sponsor.

NCT NCT04639492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04639492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect and Safety of Postbiotic MBS and Metformin Combination on Gut Microbiota and Symptom in Patients With Diabetes
Lead sponsor
Microbio Co Ltd
Phase
Not applicable
Overall status
Completed
Start date
November 2, 2020
Completion date
September 23, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type-ii diabetes